HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sophie Duvert-Lehembre Selected Research

Immunosorbents

1/2022Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study.
1/2020Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.
3/2017Sensitivity and specificity of BP180 NC16A enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis.
5/2013Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sophie Duvert-Lehembre Research Topics

Disease

4Pemphigus (Pemphigus Vulgaris)
01/2020 - 05/2013
2Bullous Pemphigoid (Pemphigoid)
01/2022 - 05/2013
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
01/2021
1Skin Diseases (Skin Disease)
01/2019
1Pathologic Complete Response
05/2017
1Muscular Diseases (Myopathy)
05/2017
1Pemphigoid Gestationis (Herpes Gestationis)
03/2017
1Neoplasms (Cancer)
05/2013

Drug/Important Bio-Agent (IBA)

4EnzymesIBA
01/2022 - 05/2013
4ImmunosorbentsIBA
01/2022 - 05/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 10/2013
2Rituximab (Mabthera)FDA Link
01/2020 - 05/2017
1AntibodiesIBA
01/2022
1VemurafenibIBA
01/2021
1Biological ProductsIBA
01/2020
1DesmogleinsIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2019
1Immunoglobulin A (IgA)IBA
01/2019
1Prednisone (Sone)FDA LinkGeneric
05/2017
1AutoantibodiesIBA
05/2013
1KalininIBA
05/2013
1SaltsIBA
05/2013
1Matrix Metalloproteinases (MMPs)IBA
05/2013

Therapy/Procedure

3Therapeutics
01/2020 - 10/2013
2Aftercare (After-Treatment)
01/2022 - 01/2020
1Duration of Therapy
10/2013